Benchmark Financial Wealth Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1757706 BOCA RATON, FL

Position in LLY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$1,170,643

+$282,146 QoQ

Shares Held

976

+1.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

#2,988

of 4,605 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Benchmark Financial Wealth Advisors, LLC holds $6,259,679 across 8 Drug Manufacturers - General names. LLY ranks #2 (18.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	26,443	$1,523,645
2	LLY	ELI LILLY & Co This page	976	$1,170,643
3	MRK	Merck & Co., Inc.	7,860	$1,010,010
4	ABBV	AbbVie Inc.	3,881	$976,614
5	AMGN	Amgen Inc	1,801	$652,178
6	PFE	Pfizer Inc	14,858	$357,780
7	JNJ	Johnson & Johnson	1,211	$307,557
8	NVS	Novartis AG	1,667	$261,252

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,170,643	976	+1.0%	Shares	Sole	2026-07-17
2026-03-31	$888,497	966	+9.9%	Shares	Sole	2026-04-27
2025-12-31	$944,643	879	+0.6%	Shares	Sole	2026-01-27
2025-09-30	$666,862	874	-4.2%	Shares	Sole	2025-10-22
2025-06-30	$710,931	912	+3.1%	Shares	Sole	2025-08-05
2025-03-31	$730,930	885	+3.1%	Shares	Sole	2025-04-25
2024-12-31	$662,376	858	-1.5%	Shares	Sole	2025-01-27
2024-09-30	$771,653	871	+1.9%	Shares	Sole	2024-10-30
2024-06-30	$774,099	855	-2.8%	Shares	Sole	2024-07-23
2024-03-31	$684,604	880	+7.4%	Shares	Sole	2024-04-22
2023-12-31	$477,411	819	+1.4%	Shares	Sole	2024-01-23
2023-09-30	$434,001	808	+2.4%	Shares	Sole	2023-10-13
2023-06-30	$370,025	789	—	Shares	Sole	2023-07-25
No filing history on record for this holder in this stock.